Stage I Marginal Zone Lymphoma Completed Phase 0 Trials for Filgrastim (DB00099)

Indication	Status	Phase
DBCOND0029479 (Stage I Marginal Zone Lymphoma)	Completed	0

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00017381	Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma	Treatment	Cyclophosphamide (DB00531) Filgrastim (DB00099) Rituximab (DB00073)